In silico study predicts a key role of RNA-binding domains 3 and 4 in nucleolin-miRNA interactions.

San, Avdar; Palmieri, Dario; Saxena, Anjana; Singh, Shaneen

San, Avdar; Palmieri, Dario; Saxena, Anjana; Singh, Shaneen.

Affiliation

San A; Department of Biology, Brooklyn College, The City University of New York, Brooklyn, New York, USA.
Palmieri D; The Biochemistry PhD Program, The Graduate Center of the City University of New York, New York, New York, USA.
Saxena A; Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Singh S; Department of Biology, Brooklyn College, The City University of New York, Brooklyn, New York, USA.

Proteins ; 90(11): 1837-1850, 2022 11.

Article in En | MEDLINE | ID: mdl-35514080

Subject(s)

Antineoplastic Agents; MicroRNAs; Carcinogenesis; Humans; MicroRNAs/genetics; MicroRNAs/metabolism; Phosphoproteins/chemistry; Phosphoproteins/genetics; Phosphoproteins/metabolism; RNA-Binding Motifs/genetics; RNA-Binding Proteins/chemistry; Nucleolin

Key words

Nucleolin; RNA binding domain; RNA binding protein; RNA-protein docking; miRNA; modeling; pri-miRNA

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Proteins Journal subject: BIOQUIMICA Year: 2022 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google